The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? [electronic resource]
Producer: 20021213Description: 653-68 p. digitalISSN:- 0923-7534
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Female
- Humans
- Male
- Neoplasms -- diagnosis
- Octreotide -- adverse effects
- Peptides, Cyclic -- adverse effects
- Randomized Controlled Trials as Topic
- Sensitivity and Specificity
- Somatostatin -- adverse effects
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.